These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 20381359)
1. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. Terracciano S; Di Micco S; Bifulco G; Gallinari P; Riccio R; Bruno I Bioorg Med Chem; 2010 May; 18(9):3252-60. PubMed ID: 20381359 [TBL] [Abstract][Full Text] [Related]
2. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222. Di Micco S; Terracciano S; Bruno I; Rodriquez M; Riccio R; Taddei M; Bifulco G Bioorg Med Chem; 2008 Sep; 16(18):8635-42. PubMed ID: 18715788 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for the design and synthesis of selective HDAC inhibitors. Di Micco S; Chini MG; Terracciano S; Bruno I; Riccio R; Bifulco G Bioorg Med Chem; 2013 Jul; 21(13):3795-807. PubMed ID: 23693069 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents. Huang D; Li X; Sun L; Xiu Z; Nishino N J Pept Sci; 2012 Apr; 18(4):242-51. PubMed ID: 22253009 [TBL] [Abstract][Full Text] [Related]
5. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones. Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224 [TBL] [Abstract][Full Text] [Related]
6. New aryldithiolethione derivatives as potent histone deacetylase inhibitors. Tazzari V; Cappelletti G; Casagrande M; Perrino E; Renzi L; Del Soldato P; Sparatore A Bioorg Med Chem; 2010 Jun; 18(12):4187-94. PubMed ID: 20576572 [TBL] [Abstract][Full Text] [Related]
7. Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors. Rossi C; Porcelloni M; D'Andrea P; Fincham CI; Ettorre A; Mauro S; Squarcia A; Bigioni M; Parlani M; Nardelli F; Binaschi M; Maggi CA; Fattori D Bioorg Med Chem Lett; 2011 Apr; 21(8):2305-8. PubMed ID: 21420859 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of a potent histone deacetylase inhibitor. Liu T; Kapustin G; Etzkorn FA J Med Chem; 2007 May; 50(9):2003-6. PubMed ID: 17419603 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors. Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel isoxazole-based HDAC inhibitors. Conti P; Tamborini L; Pinto A; Sola L; Ettari R; Mercurio C; De Micheli C Eur J Med Chem; 2010 Sep; 45(9):4331-8. PubMed ID: 20637529 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity. Chetan B; Bunha M; Jagrat M; Sinha BN; Saiko P; Graser G; Szekeres T; Raman G; Rajendran P; Moorthy D; Basu A; Jayaprakash V Bioorg Med Chem Lett; 2010 Jul; 20(13):3906-10. PubMed ID: 20605448 [TBL] [Abstract][Full Text] [Related]
12. Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors. Angibaud P; Van Emelen K; Decrane L; van Brandt S; Ten Holte P; Pilatte I; Roux B; Poncelet V; Speybrouck D; Queguiner L; Gaurrand S; Mariën A; Floren W; Janssen L; Verdonck M; van Dun J; van Gompel J; Gilissen R; Mackie C; Du Jardin M; Peeters J; Noppe M; Van Hijfte L; Freyne E; Page M; Janicot M; Arts J Bioorg Med Chem Lett; 2010 Jan; 20(1):294-8. PubMed ID: 19906529 [TBL] [Abstract][Full Text] [Related]
13. Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors. Galletti P; Quintavalla A; Ventrici C; Giannini G; Cabri W; Penco S; Gallo G; Vincenti S; Giacomini D ChemMedChem; 2009 Dec; 4(12):1991-2001. PubMed ID: 19821480 [TBL] [Abstract][Full Text] [Related]
14. [Synthesis and activity of some new histone deacetylases inhibitors]. Cheng YH; Guo YS; Han HZ; Wang N; Zhang GH; Guo ZR; Wu S Yao Xue Xue Bao; 2010 Jun; 45(6):735-41. PubMed ID: 20939182 [TBL] [Abstract][Full Text] [Related]
15. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors. Zhang Y; Feng J; Liu C; Zhang L; Jiao J; Fang H; Su L; Zhang X; Zhang J; Li M; Wang B; Xu W Bioorg Med Chem; 2010 Mar; 18(5):1761-72. PubMed ID: 20171895 [TBL] [Abstract][Full Text] [Related]
17. Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents. Oanh DT; Hai HV; Park SH; Kim HJ; Han BW; Kim HS; Hong JT; Han SB; Hue VT; Nam NH Bioorg Med Chem Lett; 2011 Dec; 21(24):7509-12. PubMed ID: 22036991 [TBL] [Abstract][Full Text] [Related]
18. A structure-based virtual screening approach toward the discovery of histone deacetylase inhibitors: identification of promising zinc-chelating groups. Park H; Kim S; Kim YE; Lim SJ ChemMedChem; 2010 Apr; 5(4):591-7. PubMed ID: 20157916 [TBL] [Abstract][Full Text] [Related]
19. Discovery of the first histone deacetylase 6/8 dual inhibitors. Olson DE; Wagner FF; Kaya T; Gale JP; Aidoud N; Davoine EL; Lazzaro F; Weïwer M; Zhang YL; Holson EB J Med Chem; 2013 Jun; 56(11):4816-20. PubMed ID: 23672185 [TBL] [Abstract][Full Text] [Related]
20. Inside HDAC with HDAC inhibitors. Bertrand P Eur J Med Chem; 2010 Jun; 45(6):2095-116. PubMed ID: 20223566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]